Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine

Lancet. 2021 Mar 27;397(10280):1178-1181. doi: 10.1016/S0140-6736(21)00502-X. Epub 2021 Feb 25.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • BNT162 Vaccine
  • COVID-19 / immunology*
  • COVID-19 Vaccines / administration & dosage*
  • Enzyme-Linked Immunospot Assay
  • Humans
  • Immunity, Humoral / drug effects*
  • Middle Aged
  • SARS-CoV-2 / immunology*
  • Spike Glycoprotein, Coronavirus / immunology*
  • T-Lymphocytes / drug effects*

Substances

  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • BNT162 Vaccine